Major advancements in artificial intelligence (AI) have attracted billions of dollars in new investment, and the IPO market has taken notice. The percentage of US IPOs referencing AI in their prospectuses has climbed in each of the past six years, and leapt to...read more
The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
WalkMe, an AI-powered enterprise customer engagement and business insight platform, raised $287 million by offering 9.3 million shares at $31, within the range of $29 to $32. WalkMe's no-code Digital Adoption Platform overlays any application and provides...read more
Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise...read more
AI is the IPO market's next buzzword
Major advancements in artificial intelligence (AI) have attracted billions of dollars in new investment, and the IPO market has taken notice. The percentage of US IPOs referencing AI in their prospectuses has climbed in each of the past six years, and leapt to...read more
US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week
The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL)...read more
Israeli business insight platform WalkMe prices US IPO at $31, within the range
WalkMe, an AI-powered enterprise customer engagement and business insight platform, raised $287 million by offering 9.3 million shares at $31, within the range of $29 to $32. WalkMe's no-code Digital Adoption Platform overlays any application and provides...read more
US IPO Week Ahead: Biotechs and software lead a 15 IPO week
Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise...read more